ClinicalTrials.gov record

Completed Early Phase 1 Interventional Accepts healthy volunteers Results available

Benzo[a]Pyrene Ultralow Dose-Response Study

ClinicalTrials.gov ID: NCT03318978

Public ClinicalTrials.gov record NCT03318978. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID: NCT03318978
Recruitment status: Completed
Study type: Interventional
Phase: Early Phase 1
Lead sponsor: Oregon State University; Other
Enrollment: 8 participants

Conditions and interventions

Conditions

Environmental Exposure

Interventions

[14C]-benzo[a]pyrene Drug

Drug

Eligibility (public fields only)

Age range: 21 Years to 65 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 16, 2018
Primary completion: Dec 31, 2023
Completion: Jan 31, 2024
Last update posted: May 21, 2025

2018 – 2024

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Clinical Research Facility, 407 Linus Pauling Science Center, Oregon State University	Corvallis	Oregon	97331	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT03318978, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 21, 2025 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03318978 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →